Table III.
Additional Imaging, Additional Biopsies, and Primary Surgical Treatment in Relation to Preoperative MRI for Women with an Interval Cancer or Screen-detected Cancer
| Interval Cancer Diagnosis | Screen-detected Cancer Diagnosis | |||||||
|---|---|---|---|---|---|---|---|---|
| MRI (N=43; 21.3%) | No MRI (161; 78.9%) | MRI (N=162; 12.9%) | No MRI (N=1092; 87.1%) | |||||
| N | % | N | % | N | % | N | % | |
| Additional Imaging (Mammogram/Ultrasound) | 13 | 30.2 | 35 | 21.7 | 67 | 41.4 | 309 | 28.3 |
|
| ||||||||
| Additional Biopsies | SCSα | SCS | 95 | 59.0 | 150 | 92.6 | 725 | 66.4 |
|
| ||||||||
| Primary Surgical Treatment | ||||||||
| Breast conserving surgery | 26 | 60.5 | 95 | 59.8 | 120 | 74.5 | 852 | 78.2 |
| Mastectomy | 17 | 39.5 | 64 | 40.3 | 41 | 25.5 | 237 | 21.8 |
SCS: Small cell size.